1. |
Zhu ZJ, Hu Y, Zhao YF, et al. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma. Ann Thorac Surg, 2011, 91 (5): 1502-1508.
|
2. |
许亚萍, 毛伟敏, 马胜林, 等. 食管癌根治性治疗后局部复发患者的预后因素分析. 中华肿瘤杂志, 2011, 33 (12):925-928.
|
3. |
蔡英杰, 何泽锋, 柯孙葵, 等. 胸段食管癌锁骨上淋巴结清扫的临床价值. 中国胸心血管外科临床杂志, 2013, 20 (1):63-66.
|
4. |
王旭广, 毛志福, 师晓天, 等. 胸段食管鳞癌淋巴结合理廓清范围的探讨. 中国胸心血管外科临床杂志, 2005, 12 (2):136-138.
|
5. |
Zhang X, Zhong JL, Liu W, et al. N (3)-o-toluyl-fluorouracil inhibitshuman hepatocellular carcinoma cell growth via sustained release of 5-FU. Cancer Chemother Pharmacol, 2010, 66 (1): 11-19.
|
6. |
Mc CP, Woolfson AD, Keating SM. Sustained release of 5-fluorouracil from polymeric nanoparticles. J Pharm Pharmacol, 2000, 52 (12): 1451-1459.
|
7. |
Frazier JL, Wang PP, Case D, et al. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intra-cranial glioma. J Neurooncol, 2003, 64 (3): 203-209.
|
8. |
刘华顶, 王世亮, 武四化, 等. 术中植入缓释氟尿嘧啶治疗大肠癌临床研究. 腹部外科, 2005, 18 (3):175-176.
|
9. |
李文献, 黄国胜, 徐正顺, 等. 食管癌术中植入缓释氟尿嘧啶间质化疗的临床研究. 陕西医学杂志, 2007, 36 (5):580-581, 586.
|
10. |
江洪, 周星明, 严福来, 等. 食管癌术中植入5-氟尿嘧啶缓释剂的安全性. 中国肿瘤, 2006, 15 (4):262-264.
|
11. |
Lee SJ, Lee KS, Yim YJ, et al. Recurrence of squamous cell carci-noma of the oesophagus after curative surgery: rates and patterns onmaging studies correlated with tumour location and pathological stage. Clin Radiol, 2005, 60 (5): 547-554.
|
12. |
Seitz JF, Duffaud F, Dahan L, et al. Adenoearcinomas of the distal esophagus and gastric cardia:what chemotherapy or chemoradiotherapy for rccurrent or metastatic disease?Cancer Radiother, 2001, 5 (Suppl 1): 107-112.
|
13. |
Shioyama Y, Nakamura K, Ohga S, et al. Radiation therapy for recurrent esophageal Cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oncol, 2007, 37 (12): 918-923.
|
14. |
Jingu K, Nemoto K, Matsushita H, et al. Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal Cancer. BMC Cancer, 2006, 6 (1): 50.
|
15. |
Nemoto K, Matsushita H, Ogawa Y, et al. Radiation therapy comb- ined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer. Am J Clin Oncol, 2003, 26 (1): 46-49.
|
16. |
毛友生, 赫捷, 程贵余. 我国食管癌外科治疗的现状与未来对策. 中华肿瘤杂志, 2010, 32 (6):401-404.
|
17. |
李幼梅, 祝淑钗, 刘志坤, 等. 胸段食管癌的淋巴结转移规律及其对确定术后放射治疗靶区范围的价值. 中华肿瘤杂志, 2010, 32 (5):391-395.
|
18. |
Nakamura T, Ota M, Narumiya K, et al. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol, 2008, 15 (9): 2451-2457.
|
19. |
Chao YK, Chan SC, Chang HK, et al. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur J Surg Oncol, 2009, 35 (3): 289-294.
|
20. |
何金涛, 李强, 朱江. 食管癌术后吻合口局部复发的再手术治疗. 临床肿瘤学杂志, 2008, 13 (1):77-78.
|
21. |
Nishimura Y, Koike R, Nakamatsu K, et al. Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperativerecurrent or residual esophageal cancer. Jpn J Clin Oncol, 2003, 33 (7): 341-345.
|
22. |
Jingu K, Nemoto K, Matsushita H, et al. Results of radiationtherapy combined with nedaplatin (cis-diammine-glycoplatinum)and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer, 2006, 6: 50.
|
23. |
Nemoto K, Matsushita H, Ogawa Y, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal Cancer. Am J Clin Oncol, 2003, 26 (1): 46-49.
|
24. |
Shioyama Y, Nakamura K, Ohga S, et al. Radiation therapy for recurrent esophageal Cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oncol, 2007, 37 (12): 918-923.
|